Back to results
US 2010/0249164 A1Published application
Modulation of sleep with nr2b receptor antagonists
OwnerJohn J. Renger, Christopher J. Winrowinventors
Life of this patent
Estimating the term…
Abstract
An NR2B receptor antagonist is useful, alone or in combination with other agents, for promoting wakefulness, treating narcolepsy, excessive daytime sleepiness, enhancing cognition, treating sleepiness associated with Alzheimer's disease, Parkinson's disease, fibromyalgia, chronic pain, sleep disorders, autism and attention deficit hyperactivity disorder.
Claims10
A method for promoting wakefulness;
- treating narcolepsy;
- treating excessive daytime sleepiness;
- enhancing cognition;
- or treating sleepiness associated with Alzheimer's disease, Parkinson's disease, fibromyalgia, chronic pain, sleep disorders, autism or attention deficit hyperactivity disorder, in a patient in need thereof that comprises administering to the patient a therapeutically effective amount of an NR2B receptor antagonist or a pharmaceutically acceptable salt thereof.
1 more element
Dependencies are inferred from the claim text.